InvestorsHub Logo
Followers 7
Posts 354
Boards Moderated 0
Alias Born 08/12/2019

Re: sts66 post# 351242

Wednesday, 08/18/2021 5:49:27 PM

Wednesday, August 18, 2021 5:49:27 PM

Post# of 430553
PFE settled for 50% on sales in the Myovant deal in which they paid 600M upfront with an additional 3.6B in sales and regulatory milestones for Relugolix in prostate and two female deseases in US territory. And they split certain sales costs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News